ORAL IRON-BASED PHOSPHATE BINDER, FERRIC CITRATE, INCREASES IRON MEASURES IN DIALYSIS-DEPENDENT AND NON-DIALYSIS DEPENDENT PATIENTS WITH CHRONIC KIDNEY DISEASE

被引:0
|
作者
Fishbane, S. [1 ]
Loram, L. [2 ]
Ganz, T. [3 ]
机构
[1] Hofstra North Shore LIJ Sch Med, Dept Med, Great Neck, NY USA
[2] Keryx Biopharmaceut, Boston, MA USA
[3] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
E1495
引用
收藏
页码:598 / 599
页数:2
相关论文
共 50 条
  • [1] FERRIC CITRATE INCREASES HEMOGLOBIN IN PATIENTS WITH NON-DIALYSIS-DEPENDENT CHRONIC KIDNEY DISEASE AND IRON DEFICIENCY ANEMIA.
    Pergola, P. E.
    Fishbane, S.
    Neylan, J. F.
    Uhlig, K.
    Chertow, G. M.
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2017, 69 (04) : A76 - A76
  • [2] Roxadustat regulates iron metabolism in dialysis-dependent and non-dialysis- dependent chronic kidney disease patients: A meta-analysis
    Hou, Yan-Pei
    Wang, Chang
    Mao, Xin-Yue
    Zhang, Man-Zhu
    Li, Bing
    JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2022, 121 (11) : 2288 - 2299
  • [3] Vadadustat for Anemia in Patients with Dialysis-Dependent or Non-Dialysis-Dependent Chronic Kidney Disease
    Bunn, H. Franklin
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 385 (16):
  • [4] Osteosarcopenia in patients with non-dialysis dependent chronic kidney disease
    Montenegro, Julia
    Klein, Arcia Regina Simas Torres
    Bregman, Rachel
    Prado, Carla M.
    Silva, Maria Ines Barreto
    CLINICAL NUTRITION, 2022, 41 (06) : 1218 - 1227
  • [5] AURYXIA (FERRIC CITRATE), AN ORAL IRON-BASED PHOSPHATE BINDER SIGNIFICANTLY IMPROVES SERUM IRON MEASURES IN PATIENTS WITH STAGE 3, 4 AND 5 CHRONIC KIDNEY DISEASE (CKD)
    Fishbane, Steven
    Block, Geoffrey A.
    Loram, Lisa C.
    Chertow, Glenn M.
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2015, 65 (04) : A35 - A35
  • [6] Iron deficiency in non-dialysis chronic kidney disease
    Fishbane, Steven
    Singh, Ajay K.
    KIDNEY INTERNATIONAL, 2009, 75 (07) : 752 - 754
  • [7] INTRAVENOUS FERRIC CARBOXYMALTOSE VS ORAL IRON IN ANAEMIC PATIENTS WITH NON-DIALYSIS DEPENDENT CHRONIC KIDNEY DISEASE AND IRON DEFICIENCY: RESULTS OF THE RANDOMISED FIND-CKD STUDY
    Macdougall, I. D.
    Bock, A.
    Carrera, F.
    Eckardt, K-U
    Gaillard, C.
    Van Wyck, D.
    Roubert, B.
    Nolen, J.
    Roger, S. D.
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2014, 29 : 21 - 21
  • [8] Iron and Clinical Outcomes in Dialysis and Non-Dialysis-Dependent Chronic Kidney Disease Patients
    Kovesdy, Csaba P.
    ADVANCES IN CHRONIC KIDNEY DISEASE, 2009, 16 (02) : 109 - 116
  • [9] Efficacy and safety of oral iron supplementation with liposomal iron in non-dialysis chronic kidney disease patients with iron deficiency
    Cesarano, Davide
    Campilongo, Giorgia
    Papadia, Federica
    De Marco, Antonia
    Borrelli, Silvio
    Cirillo, Pietro
    Minutolo, Roberto
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2024, 39
  • [10] Efficacy and safety of oral iron supplementation with liposomal iron in non-dialysis chronic kidney disease patients with iron deficiency
    Cesarano, Davide
    Campilongo, Giorgia
    Papadia, Federica
    De Marco, Antonia
    Borrelli, Silvio
    Cirillo, Pietro
    Minutolo, Roberto
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2024, 39 : I2325 - I2326